I told you I invested because of CF33 and not HER-Vaxx/PD1-Vax. Those look like Ph1 clinical trial data for PD1-Vaxx and not Ph2 which was started 13 months ago??????
Anyway, yours isn't the most stupid post I've read. The EGM presentation mention 3-6 months which I've been saying for clinical trial updates for their important IP in VAXINIA/OASIS and Azer-Cel and there was a post from a supposed holder that we won't see any clinical trial updates for 12 months??? No-one corrected this post until @Taureanbull did hours later and then there were posters who still agree with that poster lol. Rightfully, IMU is focus on the IP that have Fast Track designation and path to Ph2/Ph3 registrational clinical trial which I've been saying as they allow for quicker commercialisation since Ph3 clinical trial cost extensively more and longer don't need to be done. This is why I've been saying BP will show interest end of Ph1 clinical trial so why spend funds and resource on PD1-Vaxx when they can maximise the cost of HER-Vaxx and PD1-Vaxx in a T/O????
Then there was another non holder poster who said management has pillaged IMU share holders when they spend $5-7M on operation cost per quarter outside a few quarter expenses for the manufacturing plant which was required for the Azer-Cel acquisition but have since offloaded and there are other companies who spend $2M per quarter and don't have the potential of one product let alone 5 of them.
And posters who tried to read LC's body language for an EGM presentation when the financial indicated they didn't need this CR right now as she has suggested so abstain from the recommendation and vote. LC abstaining tell me she know a CR can be done later at a higher pps in 3 months time as she knows the clinical trials for VAXINIA and OASIS are still going and going as expected just like she told the market months before the excellent clinical trial update for VAXINIA was released. Why would any RI share holders vote against the CR when it was a good CR lol.
- Forums
- ASX - By Stock
- IMU
- Why IMU is a multi multi bagger
IMU
imugene limited
Add to My Watchlist
8.33%
!
1.1¢

Why IMU is a multi multi bagger, page-29051
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $82.13M |
Open | High | Low | Value | Volume |
1.2¢ | 1.3¢ | 1.1¢ | $376.2K | 32.83M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 3534042 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 11298051 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 3464042 | 0.011 |
86 | 22843240 | 0.010 |
29 | 12914663 | 0.009 |
10 | 1865122 | 0.008 |
6 | 2065714 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 11298051 | 21 |
0.013 | 12890526 | 28 |
0.014 | 8268651 | 33 |
0.015 | 8243629 | 29 |
0.016 | 6705871 | 27 |
Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online